Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • OncoDxRx’s Breakthrough Technology Advances Gene-Drug Matching

    Jan 9, 2023, 10:20 AM by
    OncoDxRx's PGA technology is the world-first test that enables gene-drug matching for optimal treatment regimen from hundreds of anti-cancer drugs based on patients’ own gene expression profiles
    Full story
  • Battelle, AmplifyBio, Andelyn Biosciences Win Research Contract for National Institute of Neurological Disorders and Stroke

    Jan 9, 2023, 09:57 AM by
    Battelle, AmplifyBio, Andelyn Biosciences Win Research Contract for National Institute of Neurological Disorders and Stroke
    Full story
  • Wesley Vestal Named CAI's Chief People Officer; Joins Company Leadership Team

    Jan 6, 2023, 09:14 AM by
    Wesley Vestal Named CAI's Chief People Officer; Joins Company Leadership Team
    Full story
  • Molecular Devices and Advanced Solutions Life Sciences collaborate to develop 3D Biology Automation Technologies for Drug Discovery

    Jan 6, 2023, 09:12 AM by
    Molecular Devices, a leader in high-performance life sciences solutions, on Wednesday announced a new collaboration with Advanced Solutions, a biofabrication and life sciences robotics company. This new collaboration takes the form of a turnkey solution that systematically bioprints organoids in a fully-automated enclosure, with award-winning high-content imaging capabilities that inform the modeling and screening process for increased precision--enabling the industry to grow, screen, and analyze high-quality, viable, 3D cell cultures at scale.
    Full story
  • CD BioSciences Introduces Various Solutions for Autophagic Cell Death Studies

    Jan 5, 2023, 10:22 AM by
    CD BioSciences recently launched another comprehensive panel of research solutions for autophagic cell death studies.
    Full story
  • Creative Diagnostics Introduces New Hemagglutination Inhibition Assay Services

    Jan 5, 2023, 10:22 AM by
    Creative Diagnostics recently introduced Hemagglutination Inhibition Assay services to determine relative concentrations of viruses, bacteria, or antibodies.
    Full story
  • STEMart Introduces API Impurity Identification Services for Medical Devices

    Jan 5, 2023, 10:21 AM by
    STEMart has recently introduced API Impurity Identification services for global clients.
    Full story
  • Trendspotting: What’s Coming for Bio-IT in 2023

    Jan 5, 2023, 01:00 AM by User Not Found
    Bio-IT World | We spoke with several leaders in the Bio-IT World community to gain insights about their predictions for the coming year. They anticipate increased use of AI and large language models for industry breakthroughs, significant data curation and computing advancements, widespread cost streamlining, and valiant efforts in pushing the boundaries of whole-genome studies.
    Full story
  • OncoDxRx Honing Unique Transformative Technologies for Personalized Diagnostic Capability

    Jan 4, 2023, 15:35 PM by
    OncoDxRx's unique liquid biopsy technologies create another dimension beyond traditional diagnostic capability.
    Full story
  • Abzena hires Matthew Stober to lead the company through the next phase of global growth

    Jan 4, 2023, 15:34 PM by
    Matthew Stober hired as CEO and joins Abzena Board. Abzena continues growth as the leading provider of development and manufacturing services for Antibody Drug Conjugate (ADC) and complex biologics. Board enhanced with CDMO and Biologics industry luminaries to support future growth.
    Full story
  • Verana Health and Sight Sciences Collaborate on Glaucoma Research Using Curated Real-World Data from the IRIS Registry

    Jan 4, 2023, 15:33 PM by
    Verana Health and Sight Sciences Collaborate on Glaucoma Research Using Curated Real-World Data from the IRIS Registry
    Full story
  • Blue Spark Technologies to Highlight Continuous Patient Temperature Monitoring at CES 2023

    Jan 3, 2023, 11:40 AM by
    Blue Spark Technologies, Inc., a leader in wearable remote patient monitoring solutions, will showcase TempTraq® at the 2023 Consumer Electronics Show (CES) at the Las Vegas Convention Center January 5-8.
    Full story
  • OncoDxRx Demonstrating the Power of Its One-Of-A-Kind RNA Technologies to Go Beyond Diagnostics

    Jan 3, 2023, 11:38 AM by
    OncoDxRx will thus secure its forefront position to deal with cancer patients in all stages, whether in the context of cancer screening and prevention or in the context of treatment selection, recurrence monitoring or drug discovery.
    Full story
  • Mapping the Vagus Nerve: Researchers Look to Pave the Way for Bioelectronic Breakthroughs

    Jan 3, 2023, 01:00 AM by User Not Found
    Bio-IT World | Researchers have their sights set on creating a first-of-its-kind anatomical map of the vagus nerve. The NIH-supported project plans to share the map with the greater scientific community in hopes of leading to new breakthroughs in the field of bioelectronic medicine.
    Full story
  • Creative Biogene Has Established More Than 50 Engineered Zebrafish Models to Support Human Cancer Research

    Dec 29, 2022, 10:04 AM by
    Full story
  • Microbiosci Develops Microbial Cell Line Generation for Therapeutics and Diagnostic Applications

    Dec 29, 2022, 10:04 AM by
    Full story
  • Creative Biogene Has Developed GMP Lentivirus Production Service to Accelerate Cell Therapy and Gene Therapy

    Dec 29, 2022, 10:04 AM by
    Full story
  • Histobiolab Releases Over 150 FISH Probes for Hematology, Pathology and Constitutional Cytogenetics

    Dec 29, 2022, 10:03 AM by
    Full story
  • Acroscell Provides Customized Ionic Channel Expression System to Satisfy Screening Needs

    Dec 29, 2022, 10:03 AM by
    Full story
  • Creative Bioarray Develops Cell Culture Media Solutions for Biological and Pharmaceutical Research

    Dec 29, 2022, 10:01 AM by
    Full story
  • «
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98 (current)
  • 99
  • 100
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy